# Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

> **NCT02455830** · — · UNKNOWN · sponsor: **Neonatal Encephalopathy Consortium, Japan** · enrollment: 18 (estimated)

## Conditions studied

- Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)

## Interventions

- **BIOLOGICAL:** Autologous cord blood cell therapy

## Key facts

- **NCT ID:** NCT02455830
- **Lead sponsor:** Neonatal Encephalopathy Consortium, Japan
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2020-03
- **Final completion:** 2020-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455830, "Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02455830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*